Abstract Submission

Important Note: Extended abstract submission deadline 

We want to inform you that the abstract submission deadline has been extended to December 31st, 2021 (Midnight, CET)

Your abstracts provide the main added value for the conference and we encourage you to start early to think about a project that you want to share with colleagues.

We look forward to receiving your contributions! To allow time for the scientific committee to evaluate your abstracts, please submit them as soon as possible before the deadline.

Abstract Submission Extended Deadline: December 31, 2021 (Midnight, CET)

Guidelines for Submission

Before you begin, please prepare the following information:

Presenting author’s contact details
  • E-mail address
  • Full postal address
  • Daytime and evening phone number
Author and co-authors’ details (the max of the presenters must be 5)
  • Full first and family name(s) of all authors
  • Job title of all authors (only physiotherapists, psychiatrists, psychologists, occupational therapists, social workers, nurses and the relevant students are acceptable)
  • Affiliation details of all authors: Department, institution/hospital, city, state (if relevant), country
Presentation type:

I understand that I must select a specific Topic and Presentation preference for my abstract allocation, although the Scientific Committee will work hard to honour this selection, this cannot be guaranteed.

The Scientific Committee reserves the right to change the Topic and Presentation preference under which the abstract was originally submitted.

The preferred format

Oral presentation

  • Scientific oral presentation
  • Clinical oral presentation



  • Scientific e-poster
  • Clinical e-poster


Presentation of an established clinical program, methodologies, skills practice, etc.

Background: Provide a description of the contents/concepts that will be presented during the Workshop, previous experiences and justify the benefit to the field.

Purpose: What was the major reason for developing the Workshop? Which are the learning objectives?

Methods: How will the workshop be conducted? Material used? What methods, materials and principles are involved in the workshop?

Results: What are the learning outcomes that the workshop participants will achieve?

Conclusions: What are the conclusions from the Workshop? What are the suggestions for future work? What is the take-home messages and what are the implications for practice/ management/education/ policy.

Key Words: Add 3 to 5 keywords.

Scientific oral presentation

This includes presentations of original scientific data collected by the author(s).

Any established research approach: research design or research methods will be welcomed.

Background: Provide a description of the problem being analysed or evaluated and justify the reason why the research adds value to current knowledge.

Purpose: Indicate the purpose or objective(s) of the research, the hypothesis that was tested, etc.

Methods: Participants: Describe the number and relevant characteristics of the participants and the selection procedure.

Instruments: What methodological approach was used in the study and data collection?

Analysis: Describe the type of qualitative/quantitative data analysis used to assist you in interpreting your data.

Results: Briefly summarize the main findings derived from your analysis.

Conclusions and implication: What can be concluded from the analysis of your data? What is the clinical relevance? What are the suggestions for future work? The take-home message.

Key Words: Add 3 to 5 keywords.

Funding acknowledgements (if applicable): Please acknowledge any funding sources that supported your work. If the work was unfunded, please state this.

Ethics approval: In accordance with advances in research governance, we require a statement concerning the use of ethical considerations (max 20 words).

Clinically oriented papers/ clinical oral presentation

Presentations of new or original programmes, clinically oriented papers, theories and descriptions of innovative ways in which established methods have been adapted to meet the need of clinical practice.

Background: Provide a description of the perspective or aspect being analysed and justify the reason why the report adds value to current knowledge.

Purpose: What was the major reason for developing the new or adapted programme/ method/theory/resource? Any secondary objectives?

Methods: How has the programme been evaluated? What methods, materials and principles were involved in the project, and how have these been adapted and used?

Results: What has been the response to the programme method and theory when it has been used?

Conclusions: What are the conclusions from the development and evaluation? What are the suggestions for future work?

Key Words: Add 3 to 5 keywords.


Scientific or a clinically oriented e-poster

The guideline for e-posters follows those for scientific or clinical oral presentation.

Abstract title: maximum 25 words, in capital letters

Abstract text: limited to 250 words. The fonts should be Arial 11 pt.

Abstract layout. Abstracts should use the following structured format:

  • Background
  • Purpose
  • Methods
  • Results
  • Conclusions
  • Add 3 to 5 keywords.
  • Implications
  • Funding acknowledgement
  • Ethical Approval
  • References: Up to 3 references published in the last 5 years.

Remember that:

  1. Submissions may not contain patient names, hospital ID numbers or other identifying information.
  2. Use generic names of drugs instead of brand-name drugs.
  3. The online submission system will restrict the word count.
  4. The submission form allows you to store your abstract as a DRAFT until the deadline. After the deadline, if not submitted, drafts will be deleted.
  5. Click on the SUBMIT button at the end of the process in order to submit your abstract. Changes will not be possible to your abstract after it is submitted.
  6. After your abstract submittal, you will be sent an e-mail confirming your successful submission and you will receive an abstract ID number. Please refer to this abstract number in all correspondence regarding the abstract.
  7. If you do not receive a confirmation e-mail, please contact the Conference Secretariat at abstracts@ioptmh2022.com
  8. Please do not submit multiple copies of the same abstract.
  9. Upon submission, the corresponding author is responsible for informing the other authors about the status of the abstract.

Some advice:

Be concise, clear and informative in your introduction, objective and methodology.

Present your results in a logical and clear way.

Search for a visual balance between text, figures and tables, between the scientific/clinical and aesthetic balance

Abstract topic. Select the abstract topic by Selecting from the list below:

  1. Observation and assessment tools on physiotherapy in mental health
  2. Prevention in mental health, the physiotherapist contribution.
  3. Chronic Pain
  4. Prescribing the therapeutic exercise
  5. Relaxation methodologies
  6. Long COVID-19
  7. Physiotherapy in mental health for the elderly
  8. Treating people with comorbid mental health problems
  9. Interdisciplinary approach to mentally ill
  10. New technologies
  11. Health politics and economic on physiotherapy in mental health
  12. Communication skills in mental health management
  13. Improving adherence to physiotherapy in mental health
  14. Organic, including symptomatic, mental disorders (ICD F00-F09), e.g. dementia in Alzheimer disease, dementia in Parkinson’s disease
  15. Mental and behavioural disorders due to psychoactive substance use (ICD F10-F19), e.g. alcohol and drug dependent patients
  16. Schizophrenia, schizotypal and delusional disorders (ICD F20-F29)
  17. Mood [affective] disorders (ICD F30-F39), e.g. depression, bipolar disorder
  18. Neurotic, stress-related and somatoform disorders (ICD F40-F48), e.g. anxiety disorders, Post-traumatic Stress Disorder
  19. Behavioural syndromes associated with physiological disturbances and physical factors (ICD F50-F59), e.g. eating disorders, nonorganic sleep disorders, sexual dysfunction, not caused by organic disorder or disease
  20. Mental retardation (ICD F70-F79)
  21. Disorders of psychological development (ICD F80-F89), e.g. Asperger syndrome, autism spectrum disorder
  22. Behavioural and emotional disorders with onset usually occurring in childhood and adolescence (ICD F90-F98)

Rules for Submission

Please read the submission rules before submitting an abstract.

  • Abstracts should be submitted through the online platform on the website of the Conference. ABSTRACTS SUBMITTED BY EMAIL WILL NOT BE ACCEPTED.
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to IOPTMH 2022.
  • The submitting author must be the presenting author, but may not need to be the first author of the presenting abstract.
  • Each author can only submit and present a maximum of 2 abstracts.
  • The presenting author can be named as a co-author in other abstracts.
  • All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university-specific publications office (or another similar facility) or by a copy editor, prior to submission.
  • The abstracts will be reviewed based on the scientific values and clinical implications. The Scientific Committee will determine whether the submitted article will be accepted for presentation. Its decisions are final.
  • The IOPTMH 2022 reserves the right to withdraw any abstracts that do not meet the scientific or ethical standards of the conference at any point before or after acceptance

Consent, Permissions & Copyright

When submitting the abstract online, you must confirm that you agree to the following:

  • I confirm that the contact details saved in this system are those of the presenting author.
  • I confirm that I previewed this abstract and that all information is correct.
  • I understand that the content of the submitted abstract cannot be changed after the deadline of submission. If accepted, all presentations during the Conference must include the same content and follow the same outline as that described in the submitted and accepted abstract.
  • I ensure that all co-authors are aware of the content of the abstract.
  • I have obtained the consents from all the co-authors to submit the abstract to the Conference.
  • I confirm that the co-authors and I agree to release the copyright to the IOPTMH 2022 to publish your work electronically and/or in other formats. (e.g. Conference webpage, e-programme book and printed format)
  • I understand that the presenting author must be a registered participant.


  • Until February 15th 2022, you will receive confirmation if your proposal is acceptable or not.
  • Only accepted abstracts of fully registered and paid presenters will be included in the final scientific programme.
  • The presenting author is expected to attend the Conference and present his/her oral or e-poster presentation.
  • Presenters are requested to settle their registration payment by February 28th 2022.